UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 572

Sortiert nach

Psychometric Evaluation of Social Cognition and Behavior Measures in Children and Adolescents with Down Syndrome

Brain sciences, 2021-06, Vol.11 (7), p.836

2021

Link zum Volltext

Verfügbarkeit prüfen

Short-term memory outcome measures: Psychometric evaluation and performance in youth with Down syndrome

Research in developmental disabilities, 2022-01, Vol.120, p.104147-104147, Article 104147

2022

Link zum Volltext

Verfügbarkeit prüfen

133-OR: Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

9-LB: Increased Islet Expression of Somatostatin and Glucagon in Male Rats with Insulin-Dependent Type 2 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

The Centrality of Teaching Presence: Using Multiple Modes to Facilitate Collaborative Active Engagement in a Synchronous Teacher Online Learning Community

Journal of interactive learning research, 2019, Vol.30 (2), p.107

Hoffman, Emily

2019

Link zum Volltext

Verfügbarkeit prüfen

Executive Functioning, Language, and Behavioral Abilities Related to Obstructive Sleep Apnea in Down Syndrome

Journal of developmental and behavioral pediatrics, 2023-08, Vol.44 (6), p.e429

2023

Link zum Volltext

Verfügbarkeit prüfen

Implications of Using the BRIEF-Preschool With School-Age Children With Down Syndrome

American journal on intellectual and developmental disabilities, 2024-01, Vol.129 (1), p.41-55

2024

Link zum Volltext

Verfügbarkeit prüfen

Reliability of Informant-Report Measures of Executive Functioning in Children with Down Syndrome

American journal on intellectual and developmental disabilities, 2019-05, Vol.124 (3), p.220-288

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes

Frontiers in pharmacology, 2024-01, Vol.14, p.1295639-1295639

2024

Link zum Volltext

Verfügbarkeit prüfen

Effects of somatostatin receptor type 2 antagonism during insulin‐induced hypoglycaemia in male rats with prediabetes

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1547-1556

2023

Link zum Volltext

Verfügbarkeit prüfen

2-LB: Effect of Somatostatin Receptor 2 Antagonism (SSTR2a) on Oral Glucose Tolerance (OGT) in a Rat Model of Type 2 Diabetes (T2D)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Verbal Fluency Outcome Measures in Children with Down Syndrome

American journal on intellectual and developmental disabilities, 2022-07, Vol.127 (4), p.328-344

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Processing Speed and Reaction Time Outcome Measures in Children and Adolescents with Down Syndrome

International journal of environmental research and public health, 2023-03, Vol.20 (6), p.5202

2023

Link zum Volltext

Verfügbarkeit prüfen

1-LB: Evaluating the Effectiveness of the Novel Somatostatin Receptor Antagonist (SSTR2a) ZT-01 for Hypoglycemia Prevention in a Rodent Model of Type 2 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats

Endocrinology (Philadelphia), 2021-12, Vol.162 (12)

2021

Link zum Volltext

Verfügbarkeit prüfen

Graphitic Carbon Films Across Systems

Tribology letters, 2016-09, Vol.63 (3), p.1-21, Article 32

2016

Link zum Volltext

Verfügbarkeit prüfen

Relationship between Parent and Teacher Reported Executive Functioning and Maladaptive Behaviors in Children with Down Syndrome

American journal on intellectual and developmental disabilities, 2021-07, Vol.126 (4), p.324-323

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of Sleep Evaluations and Treatments in Children with Down Syndrome

Journal of developmental and behavioral pediatrics, 2016-10, Vol.37 (8), p.629

2016

Link zum Volltext

Verfügbarkeit prüfen

Child Sleep Linked to Child and Family Functioning in Children with Down Syndrome

Brain sciences, 2021-09, Vol.11 (9), p.1170

2021

Link zum Volltext

Verfügbarkeit prüfen

14-LB: Somatostatin Receptor 2 Antagonism Enhances Plasma Glucagon Levels during Insulin-Induced Hypoglycemia in a Rodent Model of Type 2 Diabetes Mellitus

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes

Frontiers in pharmacology, 2024, Vol.15, p.1302015-1302015

2024

Link zum Volltext

Verfügbarkeit prüfen

Randomized Behavioral Sleep Clinical Trial to Improve Outcomes in Children with Down Syndrome

American journal on intellectual and developmental disabilities, 2022-03, Vol.127 (2), p.149-164

2022

Link zum Volltext

Verfügbarkeit prüfen

Semantic Verbal Fluency in Youth with Down Syndrome: Analysis of Conventional and Contextual Cluster Formation

Brain sciences, 2021-12, Vol.12 (1), p.9

2021

Link zum Volltext

Verfügbarkeit prüfen

The digital literacies of early childhood educators: perceptions of collaborative online learning

Journal of early childhood teacher education, 2023-07, Vol.44 (3), p.386-407

2023

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma

Oncology (Williston Park, N.Y.), 2021-12, Vol.35 (12), p.812-815

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 572

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(514)
Mit Volltextzugriff
(486)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Psychometric Evaluation of Social Cognition and Behavior Measures in Children and Adolescents with Down Syndrome

Short-term memory outcome measures: Psychometric evaluation and performance in youth with Down syndrome

133-OR: Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats

9-LB: Increased Islet Expression of Somatostatin and Glucagon in Male Rats with Insulin-Dependent Type 2 Diabetes

The Centrality of Teaching Presence: Using Multiple Modes to Facilitate Collaborative Active Engagement in a Synchronous Teacher Online Learning Community

Executive Functioning, Language, and Behavioral Abilities Related to Obstructive Sleep Apnea in Down Syndrome

Implications of Using the BRIEF-Preschool With School-Age Children With Down Syndrome

Reliability of Informant-Report Measures of Executive Functioning in Children with Down Syndrome

Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes

Effects of somatostatin receptor type 2 antagonism during insulin‐induced hypoglycaemia in male rats with prediabetes

2-LB: Effect of Somatostatin Receptor 2 Antagonism (SSTR2a) on Oral Glucose Tolerance (OGT) in a Rat Model of Type 2 Diabetes (T2D)

Evaluating Verbal Fluency Outcome Measures in Children with Down Syndrome

Evaluating Processing Speed and Reaction Time Outcome Measures in Children and Adolescents with Down Syndrome

1-LB: Evaluating the Effectiveness of the Novel Somatostatin Receptor Antagonist (SSTR2a) ZT-01 for Hypoglycemia Prevention in a Rodent Model of Type 2 Diabetes

Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats

Graphitic Carbon Films Across Systems

Relationship between Parent and Teacher Reported Executive Functioning and Maladaptive Behaviors in Children with Down Syndrome

Use of Sleep Evaluations and Treatments in Children with Down Syndrome

Child Sleep Linked to Child and Family Functioning in Children with Down Syndrome

14-LB: Somatostatin Receptor 2 Antagonism Enhances Plasma Glucagon Levels during Insulin-Induced Hypoglycemia in a Rodent Model of Type 2 Diabetes Mellitus

Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes

Randomized Behavioral Sleep Clinical Trial to Improve Outcomes in Children with Down Syndrome

Semantic Verbal Fluency in Youth with Down Syndrome: Analysis of Conventional and Contextual Cluster Formation

The digital literacies of early childhood educators: perceptions of collaborative online learning

Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma

Suchergebnisse filtern